Senator GALLAGHER (Australian Capital Territory—Minister for the Public Service, Minister for Finance, Minister for Women, Manager of Government Business in the Senate and Vice-President of the Executive Council) (14:33): For a start, I don't accept that it was done on an honour system. I do accept that in relation to the COVID vaccine process it was a shortened process because of the urgency and the crisis that the world was in, as the pandemic rolled through. It required the vaccine being created, and then— The PRESIDENT: Senator Roberts, a point of order? Senator Roberts: Thank you, President. My question was about other vaccines or schedule 4 drugs, not the COVID vaccines. The PRESIDENT: I think the minister went to that, but I will remind her of that part of your question. Senator GALLAGHER: I guess the point I'm making, Senator Roberts, is it was a highly unusual situation to be in. I think everyone's acknowledged that the process around the approvals for the COVID vaccine were different and had been shortened, when compared to the approvals for other drugs. That is reflective of the fact that we were in a global pandemic and millions of people were dying from the effects of COVID and that we needed a vaccine in place to protect the community, and that's actually what happened through the TGA's approval processes.